UnitedHealth Group Inc (UNH) Shares Bought by ST Germain D J Co. Inc.
ST Germain D J Co. Inc. raised its holdings in UnitedHealth Group Inc (NYSE:UNH) by 6.1% during the 2nd quarter, Holdings Channel reports. The fund owned 7,372 shares of the healthcare conglomerate’s stock after buying an additional 422 shares during the period. ST Germain D J Co. Inc.’s holdings in UnitedHealth Group were worth $1,809,000 at the end of the most recent quarter.
Other institutional investors have also made changes to their positions in the company. Elkfork Partners LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at $31,953,000. Argent Trust Co lifted its stake in shares of UnitedHealth Group by 8.3% in the 4th quarter. Argent Trust Co now owns 13,911 shares of the healthcare conglomerate’s stock valued at $3,066,000 after purchasing an additional 1,061 shares during the last quarter. DF Dent & Co. Inc. acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at $328,000. Farmers National Bank lifted its stake in shares of UnitedHealth Group by 21.2% in the 4th quarter. Farmers National Bank now owns 1,400 shares of the healthcare conglomerate’s stock valued at $309,000 after purchasing an additional 245 shares during the last quarter. Finally, Lake Street Advisors Group LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at $1,603,000. 85.38% of the stock is currently owned by institutional investors.
In other UnitedHealth Group news, EVP D Ellen Wilson sold 15,393 shares of the business’s stock in a transaction on Friday, August 24th. The shares were sold at an average price of $264.29, for a total transaction of $4,068,215.97. Following the completion of the transaction, the executive vice president now owns 66,402 shares of the company’s stock, valued at approximately $17,549,384.58. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Larry C. Renfro sold 19,652 shares of the business’s stock in a transaction dated Friday, June 15th. The stock was sold at an average price of $254.55, for a total transaction of $5,002,416.60. Following the transaction, the insider now owns 153,679 shares in the company, valued at approximately $39,118,989.45. The disclosure for this sale can be found here. In the last three months, insiders have sold 60,222 shares of company stock valued at $15,526,045. Company insiders own 0.87% of the company’s stock.
UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 17th. The healthcare conglomerate reported $3.14 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.04 by $0.10. The firm had revenue of $56.09 billion during the quarter, compared to analyst estimates of $56.10 billion. UnitedHealth Group had a net margin of 5.55% and a return on equity of 22.79%. The business’s revenue was up 12.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.46 EPS. equities analysts forecast that UnitedHealth Group Inc will post 12.72 earnings per share for the current fiscal year.
UnitedHealth Group declared that its board has initiated a stock repurchase program on Wednesday, June 6th that authorizes the company to buyback 100,000,000 outstanding shares. This buyback authorization authorizes the healthcare conglomerate to reacquire shares of its stock through open market purchases. Stock buyback programs are often an indication that the company’s board believes its stock is undervalued.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 18th. Shareholders of record on Friday, September 7th will be given a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a yield of 1.34%. The ex-dividend date is Thursday, September 6th. UnitedHealth Group’s dividend payout ratio is 35.75%.
Several research firms recently issued reports on UNH. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $278.00 price objective for the company in a research note on Wednesday, May 23rd. Leerink Swann reaffirmed an “outperform” rating on shares of UnitedHealth Group in a research note on Wednesday, July 18th. BMO Capital Markets lifted their price objective on shares of UnitedHealth Group from $275.00 to $285.00 and gave the company a “buy” rating in a research note on Thursday, June 7th. Citigroup lifted their price objective on shares of UnitedHealth Group from $275.00 to $288.00 and gave the company a “$255.42” rating in a research note on Wednesday, July 18th. Finally, ValuEngine raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Wednesday, May 2nd. Twenty-one analysts have rated the stock with a buy rating, UnitedHealth Group currently has a consensus rating of “Buy” and a consensus price target of $271.14.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: Diversification Important in Investing
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.